• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 作为非侵入性诊断胃癌生物标志物的研究进展:现状与展望。

MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives.

机构信息

Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Magdeburg 39120, Germany.

Institute for Digestive Research and Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas LT-44307, Lithuania.

出版信息

World J Gastroenterol. 2018 Aug 14;24(30):3313-3329. doi: 10.3748/wjg.v24.i30.3313.

DOI:10.3748/wjg.v24.i30.3313
PMID:30122873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6092583/
Abstract

Non-invasive diagnostic biomarkers may contribute to an early identification of gastric cancer (GC) and improve the clinical management. Unfortunately, no sensitive and specific screening biomarkers are available yet and the currently available approaches are limited by the nature of the disease. GC is a heterogenic disease with various distinct genetic and epigenetic events that occur during the multifactorial cascade of carcinogenesis. MicroRNAs (miRNAs) are commonly deregulated in gastric mucosa during the infection and in stepwise manner from chronic gastritis, through preneoplastic conditions such as atrophic gastritis and intestinal metaplasia, to early dysplasia and invasive cancer. Identification of miRNAs in blood in 2008 led to a great interest on miRNA-based diagnostic, prognostic biomarkers in GC. In this review, we provide the most recent systematic review on the existing studies related to miRNAs as diagnostic biomarkers for GC. Here, we systematically evaluate 75 studies related to differential expression of circulating miRNAs in GC patients and provide novel view on various heterogenic aspects of the existing data and summarize the methodological differences. Finally, we highlight several important aspects crucial to improve the future translational and clinical research in the field.

摘要

非侵入性诊断生物标志物有助于早期识别胃癌 (GC) 并改善临床管理。遗憾的是,目前尚无敏感且特异的筛查生物标志物,且当前可用的方法受到疾病性质的限制。GC 是一种具有多种不同遗传和表观遗传事件的异质性疾病,这些事件发生在多因素致癌级联反应过程中。在 感染期间以及从慢性萎缩性胃炎、萎缩性胃炎和肠上皮化生等癌前状态,到早期发育不良和浸润性癌,胃黏膜中 miRNAs 通常会失调。2008 年血液中 miRNAs 的鉴定引发了人们对基于 miRNA 的 GC 诊断、预后生物标志物的极大兴趣。在这篇综述中,我们提供了关于 miRNAs 作为 GC 诊断生物标志物的现有研究的最新系统评价。在这里,我们系统地评估了 75 项与 GC 患者循环 miRNAs 差异表达相关的研究,并对现有数据的各种异质性方面提供了新的见解,并总结了方法学差异。最后,我们强调了几个对改善该领域未来转化和临床研究至关重要的重要方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d8/6092583/d2cdeeb67610/WJG-24-3313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d8/6092583/e13903832412/WJG-24-3313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d8/6092583/f74570517fb3/WJG-24-3313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d8/6092583/d2cdeeb67610/WJG-24-3313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d8/6092583/e13903832412/WJG-24-3313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d8/6092583/f74570517fb3/WJG-24-3313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d8/6092583/d2cdeeb67610/WJG-24-3313-g003.jpg

相似文献

1
MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives.微小 RNA 作为非侵入性诊断胃癌生物标志物的研究进展:现状与展望。
World J Gastroenterol. 2018 Aug 14;24(30):3313-3329. doi: 10.3748/wjg.v24.i30.3313.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Non-invasive diagnostic tests for Helicobacter pylori infection.幽门螺杆菌感染的非侵入性诊断测试。
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2.
4
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
5
MicroRNAs as biomarkers in spontaneous intracerebral hemorrhage: A systematic review of recent clinical evidence.微小 RNA 作为自发性脑出血的生物标志物:近期临床证据的系统评价。
Clin Neurol Neurosurg. 2022 Feb;213:107130. doi: 10.1016/j.clineuro.2022.107130. Epub 2022 Jan 14.
6
The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review.miRNA 之幻:我们距离找到子宫内膜异位症的非侵入性诊断生物标志物还有多远?系统综述。
Int J Mol Sci. 2018 Feb 17;19(2):599. doi: 10.3390/ijms19020599.
7
Shared decision-making interventions for people with mental health conditions.心理健康问题患者的共同决策干预措施。
Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Gastric Juice MicroRNAs as Potential Biomarkers for Screening Gastric Cancer: A Systematic Review.胃液微小RNA作为胃癌筛查的潜在生物标志物:一项系统评价
Anticancer Res. 2018 Feb;38(2):613-616. doi: 10.21873/anticanres.12265.
10
Serum extracellular vesicle microRNAs as potential biomarkers to predict pembrolizumab response and prognosis in metastatic non-small cell lung cancer patients.血清细胞外囊泡微小RNA作为预测转移性非小细胞肺癌患者帕博利珠单抗反应和预后的潜在生物标志物。
Front Immunol. 2025 Jun 4;16:1540906. doi: 10.3389/fimmu.2025.1540906. eCollection 2025.

引用本文的文献

1
Smoking and alcohol specific alterations in miRNA expression in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中miRNA表达的吸烟和酒精特异性改变
Discov Oncol. 2025 Aug 2;16(1):1458. doi: 10.1007/s12672-025-03308-2.
2
Exploring microRNAs in Bile Duct Stents as Diagnostic Biomarkers for Biliary Pathologies.探索胆管支架中的微小RNA作为胆道疾病的诊断生物标志物
Cancers (Basel). 2025 Mar 31;17(7):1171. doi: 10.3390/cancers17071171.
3
Liquid biopsy in gastric cancer: A snapshot of the current state of the art.胃癌中的液体活检:当前技术水平概述

本文引用的文献

1
Expression of microRNAs in the ascites of patients with peritoneal carcinomatosis and peritonitis.微 RNA 在腹膜癌病和腹膜炎患者腹水中的表达。
Cancer Cytopathol. 2018 May;126(5):353-363. doi: 10.1002/cncy.21966. Epub 2018 Jan 23.
2
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
3
Race Disparities in the Contribution of miRNA Isoforms and tRNA-Derived Fragments to Triple-Negative Breast Cancer.miRNA 异构体和 tRNA 衍生片段对三阴性乳腺癌的贡献存在种族差异。
J Liq Biopsy. 2025 Jan 20;7:100288. doi: 10.1016/j.jlb.2025.100288. eCollection 2025 Mar.
4
Advancements in non-invasive diagnosis of gastric cancer.胃癌非侵入性诊断的进展
World J Gastroenterol. 2025 Feb 14;31(6):101886. doi: 10.3748/wjg.v31.i6.101886.
5
Expression of Salivary miRNAs, Clinical, and Demographic Features in the Early Detection of Gastric Cancer: A Statistical and Machine Learning Analysis.唾液 microRNAs 的表达、临床和人口统计学特征在胃癌的早期检测中的作用:统计和机器学习分析。
J Gastrointest Cancer. 2024 Nov 9;56(1):15. doi: 10.1007/s12029-024-01136-1.
6
Layer Analysis Based on RNA-Seq Reveals Molecular Complexity of Gastric Cancer.基于 RNA-Seq 的层分析揭示了胃癌的分子复杂性。
Int J Mol Sci. 2024 Oct 22;25(21):11371. doi: 10.3390/ijms252111371.
7
The role of microRNAs in the gastric cancer tumor microenvironment.微小 RNA 在胃癌肿瘤微环境中的作用。
Mol Cancer. 2024 Aug 20;23(1):170. doi: 10.1186/s12943-024-02084-x.
8
In Pursuit of Novel Markers: Unraveling the Potential of miR-106, CEA and CA 19-9 in Gastric Adenocarcinoma Diagnosis and Staging.探索新型标志物:揭示 miR-106、CEA 和 CA19-9 在胃腺癌诊断和分期中的潜力。
Int J Mol Sci. 2024 Jul 19;25(14):7898. doi: 10.3390/ijms25147898.
9
Non-Invasive Markers for the Detection of Gastric Precancerous Conditions.用于检测胃癌前病变的非侵入性标志物
Cancers (Basel). 2024 Jun 18;16(12):2254. doi: 10.3390/cancers16122254.
10
MiRNA polymorphisms affect the prognosis of gastric cancer: insights from Xianyou, Fujian.微小RNA多态性影响胃癌预后:来自福建仙游的见解
Front Oncol. 2024 May 15;14:1355270. doi: 10.3389/fonc.2024.1355270. eCollection 2024.
Cancer Res. 2018 Mar 1;78(5):1140-1154. doi: 10.1158/0008-5472.CAN-17-1947. Epub 2017 Dec 11.
4
MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer.微小 RNA-335-5p 是胃癌转移和侵袭的潜在抑制因子。
Clin Epigenetics. 2017 Oct 17;9:114. doi: 10.1186/s13148-017-0413-8. eCollection 2017.
5
Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer.循环微小RNA特征作为胃癌淋巴结转移预测和预后潜在非侵入性生物标志物的鉴定
Oncotarget. 2017 May 10;8(39):65132-65142. doi: 10.18632/oncotarget.17789. eCollection 2017 Sep 12.
6
A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.血清外泌体微小RNA检测 panel作为胃癌的潜在生物标志物检测方法
Biochem Biophys Res Commun. 2017 Nov 25;493(3):1322-1328. doi: 10.1016/j.bbrc.2017.10.003. Epub 2017 Oct 3.
7
Influence of laboratory-related and endoscopy-related factors on the assessment of serum pepsinogens and gastrin-17.实验室相关因素和内镜相关因素对血清胃蛋白酶原和胃泌素-17评估的影响。
Eur J Gastroenterol Hepatol. 2017 Dec;29(12):1340-1345. doi: 10.1097/MEG.0000000000000952.
8
A comprehensive, cell specific microRNA catalogue of human peripheral blood.人类外周血的全面、细胞特异性微小RNA目录。
Nucleic Acids Res. 2017 Sep 19;45(16):9290-9301. doi: 10.1093/nar/gkx706.
9
Prognostic significance of low miR-144 expression in gastric cancer.miR-144 低表达对胃癌的预后意义。
Cancer Biomark. 2017 Dec 6;20(4):547-552. doi: 10.3233/CBM-170351.
10
Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis.系统评价与荟萃分析:胃蛋白酶原、胃泌素-17和抗幽门螺杆菌抗体血清检测联合用于萎缩性胃炎诊断的诊断性能
Aliment Pharmacol Ther. 2017 Oct;46(7):657-667. doi: 10.1111/apt.14248. Epub 2017 Aug 7.